In mouse models of RP, CX3CR1-/- rd10 mice experience a worsened disease progression [19] and intravitreal injection of recombinant full-length fractalkine improves photoreceptor survival in the rd10 mouse [62]. Here, CX3CR1 is linked to retinitis pigmentosa 1.